With the world’s largest population and an immense pool of untreated patients, many who qualify for various clinical testing, China poses an attractive prospect for pharmaceutical companies. US drug manufacturers are realizing the untapped potential of testing in China. Most importantly, costs... Read More
India is the world’s second most populous country after China, with a total population of about 1 billion. While much of India is rural and poor (over 70 percent of the population lives in rural areas and the per capita income is... Read More
Opportunities in China for medical device manufacturers have never been better. U.S. medical device exports to China are growing 12 percent annually. Sales to the Chinese mainland (excluding Hong Kong) reached US$275 million in 2001. U.S. exporters achieved an additional US$250 million... Read More
The government is the largest financer of biotechnology in Singapore. It is hoped that the industry will soon meet the ranks of the country’s three leading industries — electronics, engineering, and chemical manufacturing. In October 2000, Singapore’s government designated S$1 billion (US$600... Read More
Foreign companies looking to penetrate medical device markets in Asia need to pay close attention to the regulatory environment in order to handle the difficulties that await them. Japan's medical device market is the second largest market in the world, worth almost... Read More
After India's entry into the World Trade Organization (WTO), consumer goods imports and free imports greatly increased, allowing the market to slowly open up to foreign investment and medical products. This article covers the major features of the market, law and policy... Read More
Less than two years ago, the Korean government significantly revamped rules governing the prescription and sale of pharmaceuticals in that country. Prior to the reform, distinct roles between those who prescribed and sold drugs were not clearly defined. Doctors and pharmacists could... Read More
Taiwan invested over NT$20 billion (US$571 million) in biotechnology in 2001, up over 100 percent compared to 2000. Premier Chang Chun-hsiung announced last year that Taiwan’s government plans to increase its NT$10 billion (US$285.5 million) annual investment in biotechnology by 25 percent... Read More
China’s pharmaceutical market continues to grow by 10 to 15 percent per year. Many expect it to be the world’s largest pharmaceutical market by 2020, with sales topping US$60 billion by 2010. Imports from the U.S. accounted for 8.51% of the market... Read More
Recent estimates indicate that there are over 3,000 health food products sold on the market in China, including nutraceuticals, functional foods, and products based on Traditional Chinese Medicine (TCM). At least one source reports that total sales volume in China’s health food... Read More